A new modification of histone H3 affects gene expression in breast cancer.
A New Histone H3 Modification Regulates Epigenetic Programming and Gene Expression in Breast Cancer
This study is looking at a new change in a protein that might affect how genes work in breast cancer cells, and by understanding this better, we hope to find new ways to treat the disease that could help patients like you.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Ut Southwestern Medical Center NIH-funded |
| Lab location | 1 site (Dallas, United States) |
| Project ID | NIH-10978212 on NIH RePORTER |
What this research studies
This research investigates how a newly identified modification of histone H3, specifically hydroxylation on proline 16, influences gene expression and epigenetic programming in breast cancer. The study aims to understand the role of this modification in recruiting specific proteins that regulate gene expression, which may lead to changes in cancer cell behavior. By examining breast cancer cells, the researchers will explore the molecular mechanisms involved and how this modification interacts with key signaling pathways. Patients may benefit from insights gained into the underlying biology of breast cancer, potentially leading to new therapeutic strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with breast cancer who may benefit from novel therapeutic approaches targeting epigenetic regulation.
Not a fit: Patients with non-breast cancer types or those not diagnosed with cancer may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatment options that target the epigenetic mechanisms involved in breast cancer.
How similar studies have performed: While the specific modification being studied is novel, previous research has shown that targeting epigenetic modifications can be effective in cancer treatment.
Where this research is happening
Dallas, United States
- Ut Southwestern Medical Center — Dallas, United States (Active)
Researchers
- Principal investigator: Zhang, Qing — Ut Southwestern Medical Center
- Study coordinator: Zhang, Qing
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.